Manuel Aivado - 22 Mar 2022 Form 4 Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
President and Chief Executive Officer, Director
Signature
/s/ Richard Wanstall, attorney in fact for Manuel Aivado
Issuer symbol
ALRN
Transactions as of
22 Mar 2022
Transactions value $
$0
Form type
4
Filing time
24 Mar 2022, 19:44:50 UTC
Previous filing
17 Jun 2021
Next filing
30 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +1.13M $0.00 1.13M 22 Mar 2022 Common Stock 1.13M $0.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 22, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 22, 2026.

Remarks:

President and Chief Executive Officer